Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study

被引：0
|
作者：
P. Schmid
J. Krocker
G. Morack
V. Heilmann
J.-U. Blohmer
K. Michniewicz
G. Köhler
T. Schaller-Kranz
K. Possinger
D. Elling
机构：
[1] Humboldt University Berlin,Medizinische Klinik II, Department of Oncology and Hematology, Charité Campus Mitte
[2] Oskar-Ziethen-Krankenhaus,Frauenklinik
[3] Frauenklinik Buch,Klinik für Gynäkologie und Geburtshilfe, Charité Campus Mitte
[4] Universitätsfrauenklinik,Frauenklinik
[5] Humboldt Universität zu Berlin,undefined
[6] Ernst-Moritz-Arndt Universität,undefined
[7] Bristol Myers Squibb,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2004年 / 130卷
关键词：
Primary chemotherapy; Neoadjuvant; Early breast cancer; Paclitaxel; Doxorubicin; Adjuvant treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：657 / 663
页数：6
相关论文
共 50 条
  • [1] Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer:: final results of a multicenter phase II study
    Schmid, P
    Krocker, J
    Morack, G
    Heilmann, V
    Blohmer, JU
    Michniewicz, K
    Köhler, G
    Schaller-Kranz, T
    Possinger, K
    Elling, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (11) : 657 - 663
  • [2] Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer:: final results of a phase II trial
    Schmid, P
    Krocker, J
    Jehn, C
    Michniewicz, K
    Lehenbauer-Dehm, S
    Eggemann, H
    Heilmann, V
    Kümmel, S
    Schulz, CO
    Dieing, A
    Wischnewsky, MB
    Hauptmann, S
    Elling, D
    Possinger, K
    Flath, B
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1624 - 1631
  • [3] A Southwest Oncology Group randomized phase II study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer
    Lyman, GH
    Green, SJ
    Ravdin, PM
    Geyer, CE
    Russell, CA
    Balcerzak, SP
    Budd, GT
    Martino, S
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 85 (02) : 143 - 150
  • [4] A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer
    Gary H. Lyman
    Stephanie J. Green
    Peter M. Ravdin
    Charles E. Geyer
    Christy A. Russell
    Stanley P. Balcerzak
    G. Thomas Budd
    Silvana Martino
    Breast Cancer Research and Treatment, 2004, 85 : 143 - 150
  • [5] Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a Phase II study
    Rigatos, SK
    Tsavdaridis, D
    Athanasiadis, A
    Stathopoulos, JG
    Stathopoulos, GP
    ONCOLOGY REPORTS, 2003, 10 (06) : 1817 - 1819
  • [6] Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial
    Schmid, P
    Krocker, J
    Schulz, CO
    Michniewicz, K
    Dieing, A
    Eggemann, H
    Heilmann, V
    Blohmer, JU
    Sezer, O
    Elling, D
    Possinger, K
    ANTI-CANCER DRUGS, 2005, 16 (01) : 21 - 29
  • [7] Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
    Alessandro Passardi
    Ilaria Massa
    Wainer Zoli
    Lorenzo Gianni
    Carlo Milandri
    Federica Zumaglini
    Oriana Nanni
    Roberta Maltoni
    Giovanni Luca Frassineti
    Dino Amadori
    BMC Cancer, 6
  • [8] Etoposide, doxorubicin (Adriamycin) and cisplatin chemotherapy (EAP) for advanced gastric cancer - Results of a phase II study and final review
    Valle, J
    Clemons, M
    Bretti, S
    Dougall, M
    Anderson, H
    Scarffe, JH
    GI CANCER, 1998, 2 (03): : 207 - 213
  • [9] Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer
    Jong Gwang Kim
    Sang Kyun Sohn
    Hong Suk Song
    Ki-Young Kwon
    Young Rok Do
    Kyung Hee Lee
    Myung Soo Hyun
    Hun Mo Ryoo
    Sung Hwa Bae
    Keon Uk Park
    Jin Ho Baek
    Won Sik Lee
    Joo Seop Chung
    Goon Jae Cho
    Chang-Hak Sohn
    Jung Soon Jang
    Ho Young Chung
    Wansik Yu
    Cancer Chemotherapy and Pharmacology, 2007, 60
  • [10] Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Song, Hong Suk
    Kwon, Ki-Young
    Do, Young Rok
    Lee, Kyung Hee
    Hyun, Myung Soo
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Park, Keon Uk
    Baek, Jin Ho
    Lee, Won Sik
    Chung, Joo Seop
    Cho, Goon Jae
    Sohn, Chang-Hak
    Jang, Jung Soon
    Chung, Ho Young
    Yu, Wansik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (06) : 863 - 869
12345